Exhibit 24.1
VACCINEX, INC.
POWER OF ATTORNEY
Each of the undersigned directors and officers of Vaccinex, Inc., a Delaware corporation (the “Registrant”), hereby constitutes and appoints Maurice Zauderer, Ph.D. and Scott E. Royer, CFA, MBA, and each of them, with full power of substitution and resubstitution and full power to act without the other, his or her true and lawful attorney-in-fact and agent to act in such person’s name, place and stead, in any and all capacities, to execute and file with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), one or more registration statement(s) on Form S-3 relating to the offer and resale by certain selling stockholders of shares of common stock, par value $0.0001 per share, of the Registrant in connection with that certain Registration Rights Agreement, dated November 22, 2022, and any and all amendments, supplements and exhibits thereto, including pre-effective and post-effective amendments or supplements or any additional registration statement filed pursuant to Rule 462 promulgated under the Securities Act, with full power and authority to do and perform any and all acts and things necessary, appropriate or desirable to be done in the premises, or in the name, place and stead of the undersigned, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and approving all that said attorneys-in-fact or any of them and any substitute therefor may lawfully do or cause to be done by virtue thereof.
This Power of Attorney may be executed in multiple counterparts, each of which shall be deemed an original with respect to the person executing it.
| Signature | Title | Date | ||
/s/ Maurice Zauderer, Ph.D. | President, Chief Executive Officer and Director | January 12, 2023 | ||
| Maurice Zauderer, Ph.D. | (Principal Executive Officer) | |||
/s/ Scott E. Royer | Chief Financial Officer | January 12, 2023 | ||
| Scott E. Royer, CFA, MBA | (Principal Financial and Accounting Officer) | |||
/s/ Albert D. Friedberg | Chairman of the Board | January 12, 2023 | ||
| Albert D. Friedberg | ||||
/s/ Chrystyna Bedrij Stecyk | Director | January 12, 2023 | ||
| Chrystyna Bedrij Stecyk | ||||
/s/ Jacob B. Frieberg | Director | January 12, 2023 | ||
| Jacob B. Frieberg | ||||
/s/ Bala S. Manian, Ph.D. | Director | January 12, 2023 | ||
| Bala S. Manian, Ph.D. | ||||
/s/ Gerald E. Van Strydonck | Director | January 12, 2023 | ||
| Gerald E. Van Strydonck | ||||
/s/ Barbara Yanni | Director | January 12, 2023 | ||
| Barbara Yanni | ||||